Adaptimmune Therapeutics plc (ADAPY)
OTCMKTS · Delayed Price · Currency is USD
0.0467
-0.0004 (-0.80%)
At close: Nov 25, 2025
Adaptimmune Therapeutics Market Cap
Adaptimmune Therapeutics has a market cap or net worth of $12.38 million as of November 26, 2025. Its market cap has decreased by -93.92% in one year.
Market Cap
12.38M
Enterprise Value
35.00M
Revenue
65.09M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.05
Market Cap Chart
Since May 7, 2015, Adaptimmune Therapeutics's market cap has decreased from 1.22B to 12.38M, a decrease of -98.98%. That is a compound annual growth rate of -35.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 25, 2025 | 12.38M | -91.02% |
| Dec 31, 2024 | 137.84M | -23.47% |
| Dec 29, 2023 | 180.11M | -24.70% |
| Dec 30, 2022 | 239.19M | -59.17% |
| Dec 31, 2021 | 585.77M | -29.79% |
| Dec 31, 2020 | 834.26M | 561.07% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 841.29M |
| Elite Pharmaceuticals | 572.12M |
| Glass House Brands | 537.74M |
| CytoDyn | 421.60M |
| Northwest Biotherapeutics | 391.33M |
| American Oncology Network | 363.17M |
| Nika Pharmaceuticals | 311.89M |
| Silence Therapeutics | 297.57M |